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Abstract
Animal models of rheumatoid arthritis (RA) are widely used for testing potential
new therapies for RA. The most commonly used models of human RA are adjuvant-
induced arthritis (AIA) and collagen-induced arthritis in rats and mice. In this
chapter, we will focus on inflammatory and oxidative stress (OS) processes during
the development of AIA. OS is a result of increased production of reactive oxygen
species (ROS) or a reduction in the body’s endogenous antioxidant defense system.
ROS and reactive nitrogen species (RNS) can contribute to the pathogenesis of RA
by the induction of membrane oxidation, irreversible damage to proteins and DNA,
cartilage damage, and induction of bone resorption. ROS/RNS can also modulate a
variety of signaling events that control gene expression and affect cellular processes
that participate in chronic inflammation. Our research team has been studying the
course of OS during the development of rat AIA for more than a decade. We have
analyzed the course of OS using markers of lipid peroxidation (malondialdehyde, 4-
hydroxy-2-nonenal, and F-2 isoprostanes), protein carbonyls, antioxidant enzymes
(heme oxygenase and gamma-glutamyl transferase), and levels of endogenous
antioxidants (coenzyme Q10 and Q9, gamma-tocopherol) in plasma and different
tissues (joint, liver, lung, skeletal muscle, and spleen).
Keywords: animal models, arthritis, redox signaling, cachexia, antioxidants
1. Introduction
Research on animal models is necessary to better understand the etiopathology
of rheumatoid arthritis (RA) and has enabled successful new strategies for innova-
tive drug research. Recently the discovery of novel biomarkers of presymptomatic
and emerging stages of human RA focused the attention on interventions that
underlie different disease variants. This development in the field underlying RA
pathogenesis has also led to the increased need of new animal models. Integration of
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the knowledge on human and animal models will allow to create a comprehensive
“pathogenesis map” to the subset of disease they mimic [1].
Rheumatoid arthritis occurs due to the continuous deterioration of cells and
tissues that ultimately affects major organs. Both oxidative stress (OS) and inflam-
mation are considered major role players in the pathogenesis of RA [2]. Even if
there is a lot of evidence from animal models of RA and human RA, about that OS
plays an important role in tissue damage and also promotes cardiovascular diseases
in patients with RA [3]; until now, a therapeutic strategy to reduce OS in RA has not
yet been established. Thus, understanding how the OS is influencing the develop-
ment of animal and human RA is of great importance.
In this chapter, we will discuss the importance of OS in the pathogenesis of
human RA and its experimental model, rat adjuvant arthritis (AIA).
2. Pathogenesis of rheumatoid arthritis
RA is a chronic, progressive, inflammatory autoimmune disease associated with
articular, extra-articular, and systemic effects. It has been reported that RA affects
multiple comorbidities [4]. Mortality rates are more than twice as high in patients
with RA as in the general population (Wolfe et al. [5]). Although the exact cause of
RA remains unknown [5, 6], several findings suggest a genetic basis for disease
development. More than 80% of patients carry the epitope of the HLA-DRB1*04
cluster [7], and patients expressing two HLA-DRB1*04 alleles are at elevated risk
for major organ involvement and surgery related to joint destruction [8]. Environ-
mental factors, such as smoking and infection, may also influence the development,
rate of progression, and severity of RA [9, 10]. In addition to joint symptoms, many
patients experience extra-articular or systemic manifestations or both. Extra-
articular manifestations include rheumatoid nodules, vasculitis, pericarditis, uve-
itis, and rheumatoid lung [11]. Systemic manifestations include often anemia, car-
diovascular disease, osteoporosis, fatigue, and depression [12, 13]. The earliest
event in RA pathogenesis is the activation of the innate immune response that
includes the activation of dendritic cells by exogenous material and autologous
antigens. Antigen-presenting cells, including dendritic cells, macrophages, and
activated B cells, present arthritis-associated antigens to T cells. T-cell activation
and B-cell activation result in increased production of cytokines and chemokines. In
addition to antigen presentation, macrophages are involved in osteoclastogenesis
and are a major source of cytokines, including TNF-α, IL-1, and IL-6 [6, 7]. Within
the synovial membrane, there is a great increase in activated fibroblast-like
synoviocytes, which also produce inflammatory cytokines, prostaglandins, and
matrix metalloproteinases (MMPs). Synoviocytes contribute to the destruction of
cartilage and bone by secreting MMPs into the synovial fluid (SF) and by direct
invasion into these tissues [7]. Pro-inflammatory cytokines are involved in the
pathogenesis of RA [2, 14]. TNF-α and IL-6 play dominant roles in the pathobiology
of RA; however, IL-1, vascular endothelial growth factor (VEGF), and IL-17 have
also a significant impact on the disease process. These cytokines activate genes
associated with inflammatory responses, including additional cytokines and MMPs
involved in tissue degradation [6]. Th-17 lymphocytes have a critical role in syno-
vitis in RA patients [15]. TNF-α, IL-6, and IL-1 are key mediators of cell migration
and inflammation in RA [7]. IL-6 acts directly on neutrophils through membrane
IL-6 receptors that contribute to inflammation and joint destruction by secreting
proteolytic enzymes and reactive oxygen intermediates [12]. Furthermore, an
in vitro study with fibroblasts from patients with RA demonstrated the role of IL-6
in promoting neutrophil recruitment by activated fibroblasts [16]. The principal
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cause of bone erosion is the pannus that is found at the interface with the cartilage
and bone. Angiogenesis is a key process in the formation and maintenance of
pannus because invasion of cartilage and bone requires increased blood supply. In
patients with RA, many pro-angiogenic factors are expressed in synovium, among
them, VEGF plays the central role in new blood vessel development [17]. Cartilage
degradation in RA occurs when TNF-α, IL-1, and IL-6 activate synoviocytes,
resulting in the secretion of MMPs into the SF [6, 7]. Cytokines also activate
chondrocytes (Figure 1), leading to the direct release of additional MMPs into the
cartilage [7]. ROS have been produced mainly during oxidative phosphorylation
and by activated phagocytic cells during oxidative burst. It has been known that
ROS can function as a second messenger to activate nuclear factor kappa-B (NF-κB)
which orchestrates the expression of a spectrum of genes involved in the inflam-
matory response. Several cytokines, including TNF-α and IL-1β, are known initia-
tors of NF-κB activation cascade [18] and are under its transcriptional control.
Figure 1.
Pathogenesis of cartilage and bone damage in rheumatoid arthritis. MHC, major histocompatibility complex;
TCR,T-cell receptor; TACI, transmembrane activator and CAML interactor; BLyS, B-lymphocyte stimulator;
RANK, receptor activator of nuclear factor κ B; RANKL, receptor activator of nuclear factor κ B ligand; TNF,
tumor necrosis factor; INF, interferon; IL, interleukin; CR, complement receptor; RF, rheumatoid factor.
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TNF-α participates positively in the phosphorylation of kinase kappa inhibitor,
allowing NF-κB dimers (p50 and p65 portions) to migrate to the nucleus and then
bind to promoters of pro-inflammatory genes [19] and stimulate the NADPH oxi-
dase activation. Increased cytokine production driven by NF-κB can enhance
expression of vascular adhesion molecules that attract leucocytes into the joint as
well as MMPs.
3. Rat adjuvant arthritis
Animal models of arthritis play an important role in unraveling mechanisms of
chronic inflammation in rheumatoid synovial tissue. They are used extensively to
study new treatment strategies for RA. AA can be induced by intradermal or
footpad injection of heat-killed mycobacterial species, preferably in a fine suspen-
sion in a mineral or vegetable oil (CFA). The disease is restricted to susceptible
rodents, mostly certain rat strains, such as Lewis, Buffalo, Sprague-Dawley, and
Wistar rats [20]. Following AA induction with CFA, rats not only develop arthritis
but also systemic features of inflammation, such as uveitis, inflammation of the
gastrointestinal tract, and a loss in body weight that starts 24–48 h before the
clinical onset of arthritis. AA is a symmetric polyarthritis, affecting primarily the
peripheral joints. The affected joints are red, swollen, and painful. The onset of
overt clinical arthritis is seen 10–14 days following the induction of AA with CFA
(Figures 2 and 3). The first histopathological signs of arthritis, an accumulation of
mononuclear cells in connective tissues adjacent to periosteal surfaces, are already
manifested 6 days after disease induction. Approximately 10 days after disease
induction, the first radiological signs of inflammation become visible: localized
osteoporosis, with erosive lesions, and periosteal reaction. The synovial infiltrate
leads to pannus formation, resulting in cartilage deformation, and severe destruc-
tion of the joint [21]. An important component of the disease process is the traf-
ficking of arthritogenic leukocytes into the target organ. The synovial cellular
infiltrate during the initial phase of inflammation in AA consists primarily of
mononuclear cells (mostly monocytes, macrophages, and T cells) and relatively
fewer neutrophils [22]. The arthritogenic T cells migrate into the synovium before
the appearance of clinical signs of the disease [23]. Data in AA suggesting that
Figure 2.
Changes in hind paw volume during development of adjuvant-induced arthritis. Co, control healthy rats; AIA,
adjuvant-induced arthritic rats.
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immune-stimulatory DNA sequences (ISS) may be a critical factor contributing to
the chronicity of inflammation in chronic autoimmune arthritis. ISS can stimulate
the expression of co-stimulatory molecules and the production of cytokines such as
IL-12, TNF-α, and interferons by macrophages, dendritic cells, B cells, and NK cells
[24] and are capable of skewing an immune response toward a strong and
prolonged Th1 type of immunity [25]. AA has been used in the evaluation of
nonsteroidal inflammatory drugs, such as phenylbutazone and aspirin during the
early 1960s, and later in cyclooxygenase-2 inhibitors such as celecoxib. AA in rats
shares many features with human arthritis, including genetic linkage, synovial CD4
+ cells, and T-cell dependence [26].
4. Oxidative stress and inflammation
Inflammation is a natural defense mechanism against pathogens. It occurs in
many pathogenic diseases (microbial and viral infections, exposure to allergens,
radiation and toxic chemicals, autoimmune diseases, etc.). Chronic diseases linked
with higher production of ROS result in OS and variety of protein oxidations [27].
Furthermore, some oxidized proteins trigger a release of inflammatory signal mol-
ecules, and peroxiredoxin 2 (PRDX2), which has been recognized as an inflamma-
tory signal [28]. Relationship between OS and inflammation has been documented
by many authors. Evidences indicated that OS plays a pathogenic role in chronic
inflammatory diseases. Damage of OS such as oxidized proteins, glycated products,
and lipid peroxidation results in neuron degenerations mostly reported in brain
disorders [29]. ROS generated in brain tissues can modulate synaptic and non-
synaptic communication between neurons that result in neuro-inflammation and
cell death and then in neurodegeneration and memory loss [29]. Tripeptide gluta-
thione (GSH) is an intracellular thiol antioxidant; lower level of this GSH causes
higher ROS production, which results in imbalanced immune response, inflamma-
tion, and susceptibility to infection [30]. A study was conducted on the role of GSH
and its oxidized form and their regulatory function and gene expressions beyond
free radical scavenging activities linked with GSH. GSH is involved in the redox
regulation of immune system [31] through disulfide bounds between protein
Figure 3.
Changes in body mass during development of adjuvant-induced arthritis. Co, control healthy rats; AIA,
adjuvant-induced arthritic rats.
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cysteines and GSH. This process is called as glutathionylation, which regulates
signaling proteins and transcription factors [32]. Inflammatory stimuli induce the
release of PRDX2, a ubiquitous redox-active intracellular enzyme. PRDX2 is a
redox-dependent inflammatory mediator, which activates macrophages to produce
and release TNF-α. During intracellular oxidative stress GSH binds with PRDX2 and
this protein glutathionylation occurs before or during PRDX2 release, and
glutathionylated PRDX2 regulates immunity. PRDX2 is a part of inflammatory
cascade and is able to induce TNF-α release. This study showed that PRDX2 and
thioredoxin from macrophages could alter the redox balance of cell surface recep-
tors and enable the induction of inflammatory process [28].
4.1 Oxidative stress in rheumatoid arthritis
RA is one of the conditions that induces OS. A fivefold increase in mitochondrial
ROS production in whole blood and monocytes of RA patients–compared with
healthy subjects–suggests that OS is a pathogenic hallmark in RA. Free radicals are
indirectly implicated in joint damage because they also play a role as secondary
messengers in inflammatory and immune cellular response in RA. T-cell exposure
to increased OS becomes refractory to several stimuli including those for growth
and death and may perpetuate the abnormal immune response [33]. On the other
hand, free radicals can degrade directly the joint cartilage, attacking its proteogly-
can and inhibiting its synthesis [34]. Oxidative damage of hyaluronic acid and
lipoperoxidation products and oxidation of low-density lipoproteins and carbonyl
increment resulting from protein oxidation have been demonstrated in RA.
Increased levels of 4-HNE have been assessed in serum (or plasma) and synovial
fluid of patients with RA [35, 36]. Peroxidative damage induced by free radicals has
been demonstrated to play a role in the pathogenesis not only of RA but also of
systemic lupus erythematosus, progressive systemic sclerosis, diabetes mellitus
type 1, and myasthenia gravis. Increased OS has been associated with increased lipid
peroxidation in these patients. Lipid peroxidation occurs as a result of increased OS
stemming from deranged pro-oxidant/antioxidant balance and represents an
important pathogenic process in the oxygen toxicity. As a result of lipid peroxida-
tion increases in the levels of conjugated dienes, isoprostanes, 4-HNE, and
malondialdehyde have been demonstrated [37]. Study of Basu et al. [38] has shown
that blood and synovial fluid from patients with various rheumatic diseases have
high levels of both free radical-mediated F2-isoprostanes and the cyclooxygenase-
derived PGF2 metabolite. This suggests that both oxidative injury and inflammation
play a part to various degrees in these chronic inflammatory diseases. The measur-
ing of arachidonic acid metabolites in body fluids opens unique opportunities for
studying the role of lipid peroxidation [38]. ROS-induced genotoxic events have
also been linked to mutation of p53 in RA-derived fibroblast-like synoviocytes [39].
Furthermore, it has been suggested that antioxidants systems, either enzymatic or
not, are impaired in RA. Low levels of glutathione [40], tocopherols, β-carotene,
and retinols and low activities of glutathione reductase and superoxide dismutase
have been observed in patients with RA [41]. In a recent study, RA patients were, as
usually, sub-grouped according to the presence or absence of rheumatoid factor,
disease activity score, and disease duration. In addition, RA patients and healthy
controls were evaluated for the oxidant-antioxidant status by monitoring ROS pro-
duction, biomarkers of lipid peroxidation, protein oxidation, and DNA damage. The
endogenous levels of enzymatic and nonenzymatic antioxidants were also mea-
sured. RA patients showed a marked increase in ROS formation, lipid peroxidation,
protein oxidation, DNA damage, and decrease in the activity of antioxidant defense
system leading to OS, which obviously contributes to tissue damage and to the
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chronicity of the disease [42]. Oxidative modification of proteins has been shown to
elicit antibodies in a variety of diseases including systemic lupus erythematosus
(SLE), alcoholic liver disease, diabetes mellitus, and finally RA. Oxidative stress
processes enhance the reactivity of the adaptive response. Oxidation of carbohy-
drates increased the antibody response to coadministered coantigens. In addition,
the use of the Schiff base-forming agent Tucaresol during immunization with pro-
tein antigen increased T-cell-dependent immune response. Direct modification of
protein antigen has been shown to be required for the enhancement of the immune
response [43]. In SLE, oxidatively modified DNA and low-density lipoproteins
(LDL) are present and induce a premature atherosclerosis. In an animal model of
SLE, immunization with 4-hydroxy-2-nonenal (HNE)-modified autoantigens accel-
erated epitope spreading. Pentosidine, an advanced glycation end product (AGE),
and AGE-modified IgG have correlated with RA disease activity. Oxidatively modi-
fied glutamic acid decarboxylase is important in type 1 diabetes mellitus. Oxidative
modification induced fragmentation of scleroderma-specific autoantigens and seems
to be responsible for the production of autoantibodies. Growing evidence for the
involvement of oxidative damage in autoimmunity is pointing to the administration
of antioxidants could be a viable untried alternative for preventing or ameliorating
autoimmune disease [37]. OS occurring during inflammation can cause proteins to
become nonenzymatically damaged by glyoxidation. This process results in the
generation of AGE. The immunoglobulin molecule can also undergo similar
glyoxidation to generate AGE-IgG. In inflammatory arthritis, they have shown
that antibodies to AGE-IgG are specifically associated with RA, whereas the actual
formation of AGE-IgG is related to the intensity of the systemic inflammatory
response [44].
Studies focusing on direct detection of ROS and RNS found all these biomarkers
elevated in RA patients suggesting an active OS. The redox status of neutrophils
sourced from SF was measured by flow cytometry in terms of total ROS and
hydroxyl radicals. Neutrophils a major cellular component of the SF of RA patients
and their levels of ROS correlated strongly with protein carbonylation and lipid
peroxidation. In patients with RA, the strong correlation between DAS28 score,
levels of ROS, and markers of oxidative damage suggests that measurement of OS
could serve as a marker for monitoring disease severity [45]. In another study, RA
patients had significantly higher levels of ROS (O2-, H2O2) than controls. Significant
differences where monitored in serum levels of NO in patients with high activity of
disease. More intensive response in samples with higher disease activity suggests
that oxidative/nitrosative stress markers may be valuable in evaluating the RA
progression and helpful in elucidating the mechanisms of disease pathogenesis [46].
The chronic OS in the RA synovium increases ROS production in the cellular
oxidative phosphorylation and induces repetitive cycles of hypoxia/reoxygenation.
The hypoxia in RA joints whose origin is a consequence of the rapid cellular prolif-
eration induced by the inflammatory response, however, precedes inflammation at
least in an animal arthritis model [47]. From the “danger model,” in which the
synoviocyte is an impaired cell, this sequence of events could be happening in the
human disease [48]. Activated phagocytic cells can also enhance this OS during
oxidative burst. Kundu et al. [49] showed neutrophils as most important phagocytes
responsible for elevating OS in synovial infiltrates and peripheral blood of RA
patients: The basal levels of total ROS, superoxide, and hydroxyl radicals were
significantly increased in neutrophils from peripheral blood and synovial infiltrate.
Furthermore, raised levels of superoxide in neutrophils of synovial infiltrate
showed a positive correlation with NADPH oxidase activity in synovial fluid.
However, there was no major increase in the RNS generated in monocytes from
both sources.
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4.2 Oxidative stress in adjuvant arthritis
In the development of AIA, not only immunological and inflammatory patho-
logical changes are involved, but also the redox homeostasis is shifted toward
increased production of ROS and RNS. Overproduction of ROS and RNS damages
lipids, proteins, and DNA (also exhausts the natural enzymatic and nonenzymatic
antioxidant defense), which is possible to detect with different markers of oxidation
in biological structures. In human RA OS-mediated damage to lipids, proteins, and
DNA and changes in enzymatic and nonenzymatic antioxidant defense are exten-
sively studied. AIA in animals resembles the OS caused damage in human rheumatic
diseases; therefore, it is a very useful tool to study process of OS during autoim-
mune diseases. Since there has been no standard therapy to reduce OS damage in
diseases established yet, AIA could be a promising candidate for developing this
type of therapy.
4.2.1 Peroxidation of lipids
4.2.1.1 4-HNE and MDA
The 4-HNE is one of the aldehydes specific to lipid peroxidation. 4-HNE is
believed to be predominantly responsible from the cytopathologic effects seen
during OS. Any factor compatible with stress or activity of antioxidant enzymes
may trigger potentially dangerous metabolic pathway of peroxidative damage [50].
Our results showed that the level of HNE protein adducts was significantly
increased on day 14 in rat AA [51]. The level of malondialdehyde (MDA) in the
plasma of arthritic animals was also elevated [52–54] (Table 1). He et al. demon-
strated an increased level of MDA in serum of AIA rats, which was significantly
decreased by the administration of anthocyanins from cherries [53]. AA induced in
male Sprague-Dawley rats increased plasma MDA levels, levels of glutathione,
enzyme activities of SOD and GPx were decreased [55]. Also, Wang et al. demon-
strated a significant increase of MDA and moreover nitrites in plasma of AIA rats
[56]. Levels of anti-type II collagen antibody, nitrite/nitrate, and lipid peroxidation
(levels of 4-HNE and MDA) were determined in the serum, joints, and brain. CIA
elevated levels of nitrite/nitrate and 4-HNE and MDA levels in serum and the brain
[57]. We also measured an increased levels of 4-HNE and MDA in plasma and the
brain of AIA rats (Tables 1 and 2) [58].
4.2.1.2 Isoprostanes
Isoprostanes are a complex family of compounds produced from arachidonic
acid via a free radical-catalyzed mechanism. They are reliable markers of lipid
peroxidation. A strong link between lipid peroxidation and diseases associated with
ischemia-reperfusion, atherosclerosis, and inflammation has been suggested by
Oxidative stress in plasma MDA (μg/mL) HNE (ng/mL) Protein carbonyls (nmol/mL)
CO 2.4  0.39 1.54  0.16 391.2  14.34
AIA 5.79  0.44*** 2.5  0.19*** 457.72  11.09**
Values are expressed as average  standard error of mean, statistical significance (ANOVA-Tukey-Kramer post hoc
test): **p < 0.01, ***p < 0.01 vs. CO.
Table 1.
Markers of oxidative stress (malondialdehyde (MDA), 4-hydroxynonenal (HNE), and protein carbonyls) in
plasma of arthritic animals measured on day 28.
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elevated levels of F2-isoprostanes observed in such diseases. Quantification of F2-
isoprostanes as pathophysiological markers is suitable for the investigation of lipid
peroxidation in human diseases and provides an interesting biomarker of antioxi-
dant efficacy in diseases where OS might be involved [59]. There are only few
evidences about F2-isoprostanes in animal models of RA. In one of our previous
experiments, we have measured an elevated level of F2-isoprostanes in plasma of
AIA rats, which were significantly increased compared to control healthy animals
[60]. In a CIA model, authors investigated the ability of grape seed proantho-
cyanidin extract (GSPE) to reduce the development of mice arthritis. They have
found that CIA significantly increased the level of 8-isoprostane in plasma. Plasma
levels of 8-isoprostane and serum level of collagen type II-specific IgG2a in GSPE-
treated mice were significantly decreased than those in the control mice [61].
Authors demonstrated that F2-isoprostanes are increased also in the urine of CIA
mice [62]. F2-isoprostanes as an important marker of lipid peroxidation should be
more extensively studied in AIA animal models, to obtain a better picture about the
similarity with human RA.
4.2.2 Oxidation of proteins
Protein carbonyls (aldehydes and ketones) are produced directly by oxidation or
via reactions with other molecules generated by the oxidation process. Autoimmune
attack, resulting from abrogation of self-tolerance, is involved in many human
diseases. Autoimmune disease may be either organ specific (type 1 diabetes, thy-
roiditis, myasthenia gravis, and primary biliary cirrhosis) or systemic (RA, pro-
gressive systemic sclerosis, and systemic lupus erythematosus). Nearly all these
diseases have autoantibodies. Autoantibodies are typically present several years
prior to diagnosis of SLE and serve as markers for future disease. Inflammation,
infection, drugs, ROS, and environmental factors induce formation of neo-antigens
[63]. The protein thiol groups were 59% diminished by AIA. The protein carbonyls
content, an indicative of protein damage, was increased by arthritis (41%). Protein
damage in both liver and brain was estimated as the tissue content of protein
carbonyl groups. Corroborating previous results, arthritis increased protein damage
in both tissues, 55% in the liver and 51% in the brain [64]. Authors Hemshekhar
et al. [65] also showed a significant decrease in total protein thiol content with
reference to saline-fed rats up to 51 and 36.05%, respectively, in liver and spleen
homogenates of arthritic rats [65]. In a study about protective effects of green tea
extract in AIA rats, authors detected a significant OS-caused damage to proteins and
lipids in the liver, brain, and plasma [66]. The antioxidant defense, reduced in
arthritis, is improved by the green tea treatment, as shown in the restoration of the
GSH and protein thiol levels and by the tendency for normalizing the activities of
the antioxidant enzymes. In arthritis rats, we found a significant increase of protein
carbonyls in plasma [66–69] (Table 1). This finding emphasizes the role of OS in
Oxidative stress in brain MDA (μg/g tissue) HNE (ng/g tissue)
CO 5.38  0.73 3.26  0.17
AIA 10.12  1.01*** 4.78  0.5**
Values are expressed as average  standard error of mean, statistical significance (ANOVA-Tukey-Kramer post
hoc test): **p < 0.01, ***p < 0.01 vs. CO.
Table 2.
Markers of oxidative stress (malondialdehyde (MDA) and 4-hydroxynonenal (HNE) in the brain of arthritic
animals measured on day 28).
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inflammatory diseases such as AIA, not only in tissues directly affected by the
disease (cartilage, bone, and skeletal muscle) (Table 2).
4.2.3 Production of reactive oxygen species by neutrophils
Recent evidence from animal models of RA emphasized the importance of
neutrophils in the initiation and progression of AIA [70]. Progressive erosion of
articular cartilage is a prominent feature of this disease. Not surprisingly, immuno-
suppressive approaches such as blockade of CD4+ lymphocytes effectively reduce
the intensity of damage and the progression of AIA. The report of Santos et al. [71]
convincingly demonstrates a requirement not only for CD4+ lymphocytes but also
for neutrophils, the latter determined by the protective effects of neutrophil deple-
tion. The sequence of events showed that CD4+ cells are necessary for the estab-
lishment of the immune response, which leads to the recruitment of neutrophils,
with the involvement of cytokines (TNF-α, IL-1) and the IL-8 family of
chemokines. The combination of products (oxidants, proteinases, and cytokines)
from stimulated neutrophils, synovial macrophages, and lymphocytes is important
to set the stage for acute and progressive polyarthritis [72]. We assessed ROS
production in stimulated neutrophils of arthritic rats, and it was found to be
increased, with a maximum on day 14 and 21 of AIA. Neutrophils in the whole
blood of AIA animals reacted excessively to stimulation and produced 6–9 times
more ROS [73]. We also demonstrated oxidative damage of tissues in AIA: ROS
levels in the joint and the spleen were significantly elevated [74] (Table 3).
4.2.4 Levels of endogenous antioxidants
The mammal organism has several mechanisms to counteract with OS by pro-
ducing antioxidants, which are either produced in situ or externally supplied with
foods or supplements. The nonenzymatic antioxidants are distinguished as meta-
bolic antioxidants and nutrient antioxidants. Metabolic antioxidants referred also as
endogenous antioxidants such as glutathione, lipoid acid, L-arginine, melatonin,
coenzyme Q10, uric acid, bilirubin, metal-chelating proteins, and transferrin are
produced by metabolic processes, while nutrient antioxidants are compounds that
cannot be produced in the body and must be provided through foods or supple-
ments, such as vitamin E, vitamin C, carotenoids, trace metals (selenium, manga-
nese, zinc), flavonoids, and omega-3 and omega-6 fatty acids [75]. Decreased levels
of nonenzymatic antioxidant glutathione and vitamin C were observed in the liver
of AIA rats compared to the normal rats [76]. Antioxidant state showed that plasma
vitamin E, vitamin C, vitamin A, and β-carotene were significantly lower in
arthritic control rats than normal rats [77]. Reduction of plasmatic antioxidants is
indicating reduced antioxidant capacity and elevation of oxidative stress during
adjuvant arthritis which is similar to rheumatoid arthritis in human [78].
Chemiluminescence
(RLU*s)
Spontaneous PMA stimulated Neutrophil count in 1 μL of
blood
CO 41,802  2452 150,789  9159 12,174  747
AIA 168,203  12815*** 1,165,603  94470*** 40,260  3325***
RLU*s, relative light units; PMA, phorbol-12-myristate-13-acetate; values are expressed as average  standard error
of mean, statistical significance (ANOVA-Tukey-Kramer post hoc test): ***p < 0.001 vs. CO.
Table 3.
Spontaneous and stimulated chemiluminescence and neutrophil count in whole blood of arthritic rats.
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CoQ10 plays a central role in the electron transport chain and as a radical-
scavenging antioxidant; therefore we studied its level in plasma during AA. In our
experiments the arthritis process increased significantly the level of CoQ10 in com-
parison with healthy control rats. The arthritic processes also stimulated the syn-
thesis of CoQ9 (dominant form of CoQ in rats) and its transport to plasma [79]
(Table 4). In the skeletal muscle mitochondria, we have measured significant
changes in levels of α- and γ-tocopherol (Table 5).
Similarly in AIA, also in patients with RA, a depletion of endogenous antioxi-
dants was measured. The plasma concentration of beta-carotene and vitamin E,
hemoglobin, and hematocrit were significantly lower in patients with RA than in
controls. These results provide evidence for a potential role of raised lipid peroxi-
dation and lowered enzymic and nonenzymic antioxidants in RA because of its
inflammatory character. These results suggested that OS plays a very important role
in the pathogenesis of RA [80, 78].
4.2.5 Changes in antioxidant enzymes
In order to protect tissues from oxidative injuries, the body possesses enzymatic
antioxidant enzymatic systems such as superoxide dismutases and catalase
enzymes. It has been reported that AA decreases serum or synovial SOD and
catalase activities together with other endogenous antioxidant systems [81]. Ramos-
Romero et al. [82] showed a decrease in splenic catalase activity and, paradoxically,
an increase in splenic total and mitochondrial SOD in AIA. The decreased catalase
activity could be associated with the consumption of catalase in neutralizing the
H2O2. On the other hand, increased splenic SOD activities could reflect the response
of the body to increased ROS concentrations, and/or it could be due to the fact that
arthritis was in its recovery phase 1 month after its induction. Moreover, SOD
increase could also be explained by the increase in the oxidative stress found in
arthritic rats and by the increased TNF-α secretion present in arthritis [82]. Both OS
and TNF-α are shown to induce SOD synthesis [83]. It should be added that a
similar increase in SOD activity was found in the plasma of RA patients [84] and in
Plasma CoQ9TOT (μmol/L) CoQ10TOT (μmol/L) αT (μmol/L) γT (μmol/L)
CO 0.328  0.023 0.031  0.004 19.9  1.13 0.643  0.051
AIA 0.468  0.044** 0.027  0.003 21.6  0.72 0.834  0.060*
Values are expressed as average  standard error of mean, statistical significance (ANOVA-Tukey-Kramer post hoc
test): *p < 0.05, **p < 0.01 vs. CO.
Table 4.
Concentrations of total coenzyme Q9 (CoQ 9-TOT), total coenzyme Q10 (CoQ 10-TOT), α-tocopherol (αT), and
γ-tocopherol (γT) in plasma.
Skeletal muscle
mitochondria
CoQ9TOT
(μmol/L)
CoQ10TOT
(μmol/L)
αT
(μmol/L)
γT
(μmol/L)
CO 43.1  3.01 1.90  0.160 23.0  1.23 0.98  0.042
AIA 32.7  2.49* 1.63  0.187 18.7  0.829* 1.39  0.155*
Values are expressed as average  standard error of mean, statistical significance (ANOVA-Tukey–Kramer post hoc
test): *p < 0.05 vs. CO.
Table 5.
Concentrations of total coenzyme Q 9 (CoQ 9-TOT), total coenzyme Q10 (CoQ 10-TOT), α-tocopherol (αT), and
γ-tocopherol (γT) in skeletal muscle mitochondria.
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the synovial membrane of mice with collagen-induced arthritis [85]. Catalase cata-
lyzes the decomposition of hydrogen peroxide to water and oxygen, thus
preventing the oxidation of biological structures by hydrogen peroxide. Authors
demonstrated the elevated and LPO activity and NO level and decreased GSH, SOD,
and catalase activities in AIA rats [86]. OS in AIA model is depleting antioxidant
enzymes, which is in good agreement with human RA studies.
Activity of glutathione peroxidase (GPx) in blood serum and muscles of rats
with AIA increased and activity of glutathione reductase (GR) in these tissues
increased in comparison with the control. Probably, changes in enzyme activity are
a defense response of the body to ROS generation in RA and can be a result of ROS
activation or stimulation of their synthesis [87]. Similarly in the study of Sahu et al.
[88], CIA increased antioxidant enzyme GPx and GR activities in joints, liver,
kidney, and spleen tissues of rats.
Several pathologic factors have been suggested to be involved in the
overexpression of heme oxygenase-1 HO-1 in RA lesions. In addition to superoxides
and pro-inflammatory cytokines, hypoxia may play an important role in HO-1
expression in the lesions [89, 90]. AIA is an experimental model widely used to
evaluate etiopathogenetic mechanisms in chronic inflammation. Devesa et al. [91]
have examined the participation of HO-1 in AIA. They have found an increased
nitric oxide (NO) production in the paw preceded the upregulation of HO-1,
whereas selective inhibition of inducible NO synthase (iNOS) after the onset of
arthritis lowered HO-1 expression, suggesting that this enzyme may depend on NO
produced by iNOS. Administration of the HO-1 inhibitor protoporphyrin IX ame-
liorated the symptoms of arthritis. This compound significantly decreased leuko-
cyte infiltration, erosion of articular cartilage, and osteolysis, as well as the
production of inflammatory mediators. In this model, HO-1 can be involved in
vascular endothelial growth factor production and angiogenesis. These results sup-
port a role for HO-1 in mediating the progression of the disease in this model of
chronic arthritis [91]. Our research group showed that extra-articular manifesta-
tions of AIA are present also in lung, where the expression of heme oxygenase-1 was
reduced during AIA [60].
5. Potential role of free radicals in rheumatoid cachexia
Cachexia is one of the major causes of progressive weight loss and affects up to
20% of RA patients [92]. Unlike sarcopenia, which is a normal physiological process
of body mass reduction affected by aging, cachexia appears to be a secondary
manifestation of an already ongoing disease [93]. Cachexia associated with RA can
occur in two forms. The first form is cachectic RA or rheumatoid cachectic obesity,
which is manifested by severe muscle wasting, with little or no fat mass loss. It is a
less threatening form of cachexia mainly because the energy demands of muscles
can be compensated by lipid metabolism [94]. The second form is rheumatoid
cachexia, which is manifested by severe muscle wasting as well as fat loss.
Rheumatoid cachexia (RC) is a progressive form of RA, which is primarily
thought to be caused by the abnormal production of the pro-inflammatory cyto-
kines produced by the immune cells localized in the synovial tissue of the affected
joints. Excessive concentrations of several cytokines, especially TNF-α, IL-1β, IL-6,
and INF-γ, could potentially affect the intracellular mechanisms of muscle fibers,
leading to severe muscle atrophy and weakness [95]. The most dominant cytokine
in RA and RC pathogenesis appears to be TNF-α which acts synergically with IL-1β.
When bound to their specific receptors, these cytokines cause activation of NF-κB
signaling cascade. A study by Cai et al. [96] suggests that muscle atrophy is
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predominantly promoted by the NF-κB pathway via the activation of MuRF1 tran-
scription factor which ultimately induces immoderate proteolysis of muscle pro-
teins by activating the ubiquitin-proteasome system. Moreover, Castillero et al. [97]
observed overexpression of MuRF1 as well as several other myogenic factors, such
as atrogin-1/MAFbx ubiquitin ligases in adjuvant arthritis.
Another important pathogenic factor of RC is reduced physical activity, which
appears to be the result of either poor pain management of inflamed and swollen
joints, metabolic changes, or merely general caution for physical activity. Lower
physical activity leads to reduced muscle fiber stimulation, which significantly
disrupts the cycle of muscle proteolysis and proteosynthesis in favor of proteolysis
[98]. One of the possible triggers of RC could also be increased free radical concen-
tration and onset of OS.
As mentioned in the previous text, ROS and RNS concentrations have been
reported to be elevated in the joint area as well as plasma. This may indicate that an
increase in free radicals levels could also be found in skeletal muscle tissue. There
are several sites of free radical production in muscles including mitochondria,
sarcoplasmic reticulum, and sarcolemma [99]. As metabolically highly active
organs, muscles dramatically increase their oxygen consumption during physical
activity in order to compensate various energy-dependent processes. Concurrently
excessive amounts of oxidants are produced, which then serve as messenger mole-
cules in multiple intracellular cascades. The main site of free radical generation is
mitochondria during aerobic metabolism and oxidative phosphorylation. It has been
shown that complexes I and III and more recently complex II of mitochondrial
electron transport chain are key producers of ROS in muscle fibers [100]. Several
authors suggest that the major ROS produced in muscle cells is superoxide anion
(O2•), which is a very unstable radical and rapidly undergoes reduction resulting
in dismutation into hydrogen peroxide (H2O2) [101]. Even though H2O2 is quite a
stable nonradical molecule, excessive concentrations of H2O2 could ultimately result
in increased generation of hydroxyl radical (•OH)–a highly reactive ROS which
could potentially damage various cellular molecules and disrupt many intracellular
mechanisms. Free radicals are also regularly produced by several enzymes such as
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) family as
well as xanthine oxidase (XO) [99]. In skeletal muscles only Nox 2 and Nox 4
isoforms have been found, and it is believed that both of these isoforms are localized
primarily in mitochondria [102]. However, the precise mechanism by which the
increased activity of these enzymes is promoted is to date poorly understood. Under
physiological conditions, excessive concentrations of free radicals are regularly
scavenged and converted into non-radical molecules by antioxidant defense system
molecules. However, several studies have observed low concentrations of some
nonenzymatic antioxidants such as GSH [41] as well as low activity of enzymatic
antioxidants such as SOD and glutathione peroxidase (GPX) in RA, which could
potentially affect muscle tissue [103]. It has been proposed that decreased physical
activity in RC patients could play a major role in oxidative damage of muscle cells
since lower muscle stimulation reduces antioxidant capacity thus causing impaired
balance in oxidant-antioxidant ratio [104].
Several long-term studies have reported a number of negative effects of free
radicals in muscles at the molecular level. Oxidative damage of lipids, particularly in
cell membranes [105], as well as nucleic acids in the DNA [106] is of great impor-
tance to normal cellular functioning, lately there has been a great deal of emphasis
on protein modifications caused by ROS in multiple diseases.
Proteins as functional units of the cell can cause great damage to the cell itself if
its space conformation is disrupted. Perhaps the most common protein modification
caused by imbalance of oxidative status is carbonylation of side chains of multiple
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amino acids such as arginine, lysine, threonine, and proline [107]. Moreover,
carbonylation of proteins that are part of the contractile apparatus could be crucial
in RC muscle dysfunction. Fedorova et al. [108] showed that carbonylation of actin
could very much affect actomyosin ATPase activity, thus promoting subsequent
muscle atrophy. Taken together, action of pro-inflammatory cytokines, mitochon-
drial dysfunction, and enhanced activity NADPH oxidase and xanthine oxidase
contribute to the overproduction of ROS/RNS.
Decreased physical activity results in downregulation of antioxidants. Combina-
tion of these factors consequently leads to imbalance in protein synthesis and
degradation resulting in muscle wasting (Figure 4).
5.1 Animal models in rheumatoid cachexia
Rheumatoid cachexia still remains a poorly investigated disease, and many sci-
entists are trying to understand the exact mechanism by which the disease takes
place. Several animal models of RA are used in the study of this condition. The best
studied animal model to date has been CIA, which, by its characteristics, offers the
most accurate comparison with humans, as the onset of this affection is relatively
slow and the immune mechanisms driving the onset of cachexia are closest to
rheumatoid cachexia in people [109].
Recently, Albarse et al. [110] have been investigating the development of
cachexia in CIA in DBA1/J mice. In their study, they have observed significant
increase in free exploratory locomotion as well as grip strength and endurance
exercise performance. Additionally, they registered reduction of muscle weight in
several muscles, which could indicate that mechanisms, which led to the onset of
arthritis, could subsequently promote muscle atrophy and weakness.
Another model of rheumatoid arthritis and adjuvant arthritis was also used to
investigate muscle wasting in male and female Lewis rats in the study of Roubenoff
et al. [111]. It was shown that adjuvant-induced rats also manifested severe muscle
loss when compared to control as well as pair-fed groups. This makes adjuvant
arthritis suitable model for study of cachexia in chronic inflammatory diseases.
Even though there have been multiple authors dedicated to unraveling the true
cause of rheumatoid-induced cachexia, much more study is needed in order to
Figure 4.
Mechanism of the effect of oxidative stress on the onset of cachexia in rheumatoid arthritis. NOX, nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase; XO, xanthine oxidase; ROS, reactive oxygen species; RNS,
reactive nitrogen species.
14
Animal Models in Medicine and Biology
sufficiently understand precise mechanism by which this serious condition occurs.
This could greatly improve quality of RA patients and thus contribute to modern
medicine.
6. Conclusion
The animal model adjuvant arthritis gives a broad spectrum of possibilities to
study different pathological mechanism of rheumatoid arthritis. One important
pathological pathway is the connection between inflammation and oxidative stress,
which is studied on both systemic and local levels. From our original results as well
as from results reported by other authors, it is evident that treatment with com-
pounds possessing redox balance modulating properties might be of great relevance
for new strategies for therapy of rheumatoid arthritis. For this purpose, adjuvant
arthritis seems to be an ideal animal model. Moreover, this animal model has also a
good potential in the research of inflammatory cachexia and its pharmacological
intervention.
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